Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

Go back to Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer
(NASDAQ: AQST) Delayed: 5.03 +0.31 (6.57%)
Previous Close $4.72    52 Week High
Open $4.71    52 Week Low
Day High $5.11    P/E N/A 
Day Low $4.71    EPS
Volume 2,988,452